CJC-1295 with DAC 5mg

89.00€

Availability: 241 in stock

3 Products -5%

84.55 € /pc

6 Products -10%

80.10 € /pc

8 Products -15%

75.65 € /pc

Third-Party Tested

Laboratory test for this product

View the certificate of analysis and laboratory verification for this product.

View laboratory test

CJC-1295 with DAC 5 mg research-grade lyophilized peptide powder supplied in a glass vial. CJC-1295 with DAC is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH), incorporating Drug Affinity Complex (DAC) technology to enable covalent binding to serum albumin and extend circulating half-life in experimental models of GH/IGF-1 axis regulation.

Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.

Purity

High-purity research grade

Form

Lyophilized peptide powder

Content

5 mg CJC-1295 with DAC per vial

Packaging

Glass vial with sterile closure

Storage

Store lyophilized at 2–8 °C (desiccated, protect from light)

Molecular formula

C₁₆₅H₂₆₉N₄₇O₄₆

Molecular weight

~3647.1 g·mol⁻¹

Sequence / structure

Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Maleimidopropionyl)-NH₂

CAS number

863288-34-0 (Base Peptide)

Tests

CJC-1295 with DAC test

In laboratory workflows, lyophilized research peptides are typically handled with suitable sterile diluents such as bacteriostatic water (BAC). For a compatible research-only solvent, see Bacteriostatic water – 10 ml .

Research Overview

CJC-1295 with DAC is a long-acting GHRH analog based on the first 29 amino acids of human Growth Hormone-Releasing Hormone (Modified GRF 1-29), further modified with a maleimidopropionyl Drug Affinity Complex (DAC) linked via lysine. In experimental in vitro and in vivo systems, this design enables covalent binding to circulating albumin, markedly prolonging half-life and allowing sustained stimulation of GHRH receptors, growth hormone (GH) secretion and downstream insulin-like growth factor 1 (IGF-1) signaling under controlled laboratory conditions.

Primary Research Areas

Sustained GH release: used in models examining prolonged pituitary growth hormone output following extended GHRH receptor stimulation and albumin binding–mediated half-life extension.
IGF-1 axis modulation: applied in research exploring long-term elevations in circulating IGF-1, somatotropic axis activity and associated metabolic endpoints in preclinical settings.
Extended GHRH receptor agonism: used to study receptor occupancy, downstream cAMP/PKA signaling and desensitization or adaptation phenomena during chronic GHRH analog exposure.
Metabolism and body composition models: incorporated into experimental designs evaluating how prolonged GH/IGF-1 elevation influences body composition, tissue remodeling and energy metabolism markers in animals and other laboratory systems.
Pharmacokinetics of long-acting peptides: used as a model compound in studies on albumin-binding peptide drugs, half-life extension strategies and modified-release endocrine analogs.

Find out what benefits peptides have

Discover how peptides can boost recovery, improve skin health, increase energy and support overall performance. Explained simply and clearly in this short video.

Why Limitless Biochem?

Limitless BioChem is a trusted supplier of research compounds. Our products meet strict quality standards and are compliant with EU requirements. We focus on the safe and reliable supply of peptides and pure compounds intended exclusively for research or collector purposes.

This product is not intended for human or veterinary use. It is for collection or research purposes only. It cannot be used as food, dietary supplement or medicine! The information provided in the text on this page is for educational purposes only and does not constitute medical or other advice.